Clinical efficacy and safety of Chinese herbal medicine for Wilson's disease: A systematic review of 9 randomized controlled trials

Complementary Therapies in Medicine

Volumn 20, Issue 3, 2012, Pages 143-154

  Wang, Yan ^a   Xie, Cheng long ^a   Fu, Deng lei ^a   Lu, Lin ^a   Lin, Yan ^a   Dong, Qi qian ^a   Wang, Xiao tong ^a   Zheng, Guo qing ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chinese herbal medicine; Systematic review; Wilson's disease

Indexed keywords

CHAIHUANG GANDOU PULVIS; EDETATE CALCIUM DISODIUM; GANDOU; GANDOULING; HERBACEOUS AGENT; OXYMATRINE; PENICILLAMINE; RUANJIANTANGJIANG; SHUGANLIDANPAIDU; SUCCIMER; TIOPRONIN; UNCLASSIFIED DRUG; UNITHIOL; ZINC SULFATE;

ADJUVANT THERAPY; CHINESE MEDICINE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HERBAL MEDICINE; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; URINARY COPPER EXCRETION; URINARY EXCRETION; WILSON DISEASE;

COPPER; DRUGS, CHINESE HERBAL; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LIVER CIRRHOSIS; OUTCOME ASSESSMENT (HEALTH CARE); PHYTOTHERAPY;

EID: 84859697930     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2011.12.004     Document Type: Review

References (36)

1. Ala A., Walker A.P., Ashkan K., Dooley J.S., Schilsky M.L. Wilson's disease. Lancet 2007, 369(9559):397-408.
2. Behari M., Pardasani V. Genetics of Wilsons' disease. Parkinsonism Relat Disord 2010, 16(10):639-644.
3. Roberts E.A., Schilsky M.L., American Association for Study of Liver Diseases (AASLD) Diagnosis and treatment of Wilson disease: an update. Hepatology 2008, 47(6):2089-2111.
4. Członkowska A., Tarnacka B., Litwin T., Gajda J., Rodo M. Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period. J Neurol 2005, 252(6):698-703.
5. Hoogenraad T.U. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006, 28(3):141-146.
6. Wang X.P., Zhang W.F., Huang H.Y., Preter M. Neurology in the People's Republic of China - an update. Eur Neurol 2010, 64(6):320-324.
7. Yang R.M., Yang X.T., Bao Y.C., Han Y.Z., Chen W.D., Li S.Y., et al. Observation on integrative Chinese and western medicine in treatment of 418 patients with hepatolenticular degeneration. Chin J Integr Tradit West Med 1990, 10(3):134-136.
8. Yang R.M., Cheng N. Observation on short-term effect and follow-up of integrative Chinese and western medicine in treating 198 patients with hepatolenticular degeneration. Chin J Integr Tradit West Med 2002, 22(9):657-659.
9. Yang W.M., Zhao G.F., Dong T., Wang M.X., Yang X.T., Bao Y.C., et al. Advancement in treating hepatolenticular degeneration with traditional Chinese medicine. Chin J Exp Tradit Med Formul 2008, 14(2):71-73.
10. van den Berghe P.V., Stapelbroek J.M., Krieger E., de Bie P., van de Graaf S.F., de Groot R.E., et al. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology 2009, 50(6):1783-1795.
11. Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097.
12. Hepatolenticular degeneration 1995, vol. 205:167-168. Science and Technology Publishing House of Anhui, Hefei.
13. Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990, 12(5):1234-1239.
14. Practical neurology 1994, 771-772. Shanghai Science and Technology Publishing House. 2nd edition. Y. Shi (Ed.).
15. Furlan A.D., Pennick V., Bombardier C., van Tulder M., the Editorial Board of the Cochrane Back Review Group Updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009, 34(18):1929-1941.
16. Xue B.C., Yang R.M., Hu J.Y., Han Y.Z., Wang J.H. The study on the mechanism of anti-fibrosis with GanDouTang II in the treatment of patients with Wilson's disease. Anhui Med J 2007, 28(4):296-299.
17. Xue B.C., Yang R.M., Hu J.Y., Han Y.Z., Wang J.H. Effect of Gandou Decoction combined with short-term decoppering therapy with sodium dimercaptosulphonate on serum indexes of hepatic fibrosis in patients with Wilson's disease. Chin J Integr Tradit West Med 2007, 27:785-788.
18. Wang X., Zhao J., Wu J.X., Xue B.C., Cong S.B., Hu J.Y., et al. Observation and analysis on improvement of liver cirrhosis in hepatolenticular degeneration patients treated with combination of danshen powder injection with glutathione. Clin J Tradit Chin Med 2009, 21:6-8.
19. Hu J.Y., Yang R.M., Han Y.Z., Hong M.F., Wang X., Li K., et al. The clinical study of six antidotes against heavy metal poisoning in Wilson's disease. Anhui Med J 2004, 25:361-365.
20. Zhang B., Jiang T.Z., Wang X.Y., Huang W., Tong J.B., Chen Y.H., et al. Study of gandouling tablet and glutathione on hepatolenticular degeneration. J Emerg Tradit Chin Med 2010, 19:760-763.
21. Hua N., Luo L.T. Clinical observation on integrative Chinese and western medicine in treatment of 34 children with hepatolenticular degeneration. Chin J Tradit Med Sci Tec 2002, 9:365-366.
22. Ren M.S., Zhang B., Yang R.M., Yang Y.Z., Wang X. Clinical study of integrated traditional and western medicine therapy on hepatolenticular degeneration. Chin J Integr Tradit West Med 1997, 17:136-138.
23. Han Y.Z., He G.Y., Wang X., Li K., Wang G.Q., Wang R.M. Comparative study on therapeutic effects of Gandou Tablet I and dimercaptosuccinate acid in treating Wilson disease. Chin J Integr Tradit West Med 1999, 19:69-70.
24. Hong M.F., Wang G.Q., Yang R.M., Hu J.Y., Wang X.P., Lv D.P. Study on improvement of liver cirrhosis and liver function in hepatolenticular degeneration patients treated with integrated traditional and western medicine. Chin J Integr Tradit West Med 2000, 20:890-892.
25. Cui G.X., Zhao Q.W. Clinical observation on integrative Chinese and western medicine in treating 33 patients with hepatolenticular degeneration. Shandong J Tradit Chin Med 2001, 20:353-355.
26. Xiao L.M. Clinical observation on integrative Chinese and western medicine in treating liver cirrhosis in hepatolenticular degeneration patients. Hubei J Tradit Chin Med 2003, 25:9-10.
27. Chen H.Z., Cai Y.L., Wang Y.X., Xu G.C., Fan X., Hou Z.F. Clinical observation on treatment of 43 cases of hepatolenticular degeneration patients with combination of gandouling tablets with tiopronin injection. Clin J Tradit Chin Med 2007, 19:385-386.
28. Hu W.B., Wu S.M., Xue B.C., et al. Effect on index of hepatic fibrosis in serumology by combined use of kushenin and decopper therapy in treating hepatolenticular degeneration. Anhui Med Pharm J 2008, 12:1071-1072.
29. Chen J.L., Wang D.H. Clinical study on improvement of liver function and liver cirrhosis in hepatolenticular degeneration patients treated with Shuganlidanpaidu Decoction. New J Tradit Chin Med 2008, 40:28-29.
30. Chen J.L., Wang D.H. Clinical observation on treatment of 59 cases of hepatolenticular degeneration patients with chaihuanggandou pulvis. J Sichuan Tradit Chin Med 2010, 28:72-74.
31. De Angelis C., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., et al. International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004, 351(12):1250-1251.
32. Ernst E., Lee M.S. A trial design that generates only " positive" results. J Postgrad Med 2008, 54(3):214-216.
33. Schulz K.F., Altman D.G., Moher D., CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010, 7(3):e1000251.
34. Koppikar S., Dhawan A. Evaluation of the scoring system for the diagnosis of Wilson's disease in children. Liver Int 2005, 25(3):680-681.
35. Leinweber B., Möller J.C., Scherag A., Reuner U., Günther P., Lang C.J., et al. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease. Mov Disord 2008, 23(1):54-62.
36. Aggarwal A., Aggarwal N., Nagral A., Jankharia G., Bhatt M. A novel Global Assessment Scale for Wilson's Disease (GAS for WD). Mov Disord 2009, 24(4):509-518.